Giovine Salvatore 4
4 · Xilio Therapeutics, Inc. · Filed Oct 25, 2021
Insider Transaction Report
Form 4
Giovine Salvatore
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2021-10-21+28,755→ 28,755 totalExercise: $16.00Exp: 2031-10-20→ Common Stock (28,755 underlying)
Footnotes (1)
- [F1]The option award was granted on October 21, 2021 and shall begin to vest on November 1, 2021 and continue to vest in equal monthly installments thereafter until October 1, 2025.